Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term safety and tolerability of oxcarbazepine extended-release as adjunctive therapy in refractory partial epilepsy
2008-003334-19Phase 3Completed
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Start
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of oxcarbazepine in epilepsy, sponsored by Supernus Pharmaceuticals, Inc. Started May 2010; status: completed.
02
Drugs
oxcarbazepine
03
Conditions
epilepsy
Beyond the preview
Go deeper on 2008-003334-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003334-19.